Morris Schambelan, MD

Professor Emeritus

Education
Residency, - School of Medicine, University of California, San Francisco
Publications

  1. Lee AP, Mulligan K, Schambelan M, Murphy EJ, Weiss EJ. Growth hormone receptor antagonism with pegvisomant in insulin resistant non-diabetic men: A phase II pilot study. F1000Research 2017. PMID: 28713554


  2. Schwarz JM, Noworolski SM, Wen MJ, Dyachenko A, Prior JL, Weinberg ME, Herraiz LA, Tai VW, Bergeron N, Bersot TP, Rao MN, Schambelan M, Mulligan K. Effect of a High-Fructose Weight-Maintaining Diet on Lipogenesis and Liver Fat. The Journal of clinical endocrinology and metabolism 2015. PMID: 25825943


  3. Rao MN, Neylan TC, Grunfeld C, Mulligan K, Schambelan M, Schwarz JM. Subchronic sleep restriction causes tissue-specific insulin resistance. Volume 100 of Issue 4. 2015. PMID: 25658017


  4. Khanijow K, Unemori P, Leslie KS, Mulligan K, Schambelan M, Maurer T. Cutis Verticis Gyrata in Men Affected by HIV-Related Lipodystrophy. Dermatology research and practice 2013. PMID: 24159328


  5. Campos GM, Rabl C, Havel PJ, Rao M, Schwarz JM, Schambelan M, Mulligan K. Changes in post-prandial glucose and pancreatic hormones, and steady-state insulin and free fatty acids after gastric bypass surgery. Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery 2013. PMID: 24209879


  6. Park-Sigal J, Don BR, Porzig A, Recker R, Griswold V, Sebastian A, Duh QY, Portale AA, Shoback D, Schambelan M. Severe hypercalcemic hyperparathyroidism developing in a patient with hyperaldosteronism and renal resistance to parathyroid hormone. Volume 28 of Issue 3. 2013. PMID: 23074096


  7. Rao MN, Schambelan M, Tai VW, Abrams DI, Khatami H, Havel PJ, Sakkas G, Mulligan K. Assessing the Association between Leptin and Bone Mineral Density in HIV-Infected Men. AIDS research and treatment 2012. PMID: 22966425


  8. Morley JE, Abbatecola AM, Argiles JM, Baracos V, Bauer J, Bhasin S, Cederholm T, Coats AJ, Cummings SR, Evans WJ, Fearon K, Ferrucci L, Fielding RA, Guralnik JM, Harris TB, Inui A, Kalantar-Zadeh K, Kirwan BA, Mantovani G, Muscaritoli M, Newman AB, Rossi-Fanelli F, Rosano GM, Roubenoff R, Schambelan M, Sokol GH, Storer TW, Vellas B, von Haehling S, Yeh SS, Anker SD. Sarcopenia with limited mobility: an international consensus. Journal of the American Medical Directors Association 2011. PMID: 21640657


  9. Winterstein AG, Heckbert SR, Schambelan M. Intensive glucose lowering and cardiovascular outcomes. The New England journal of medicine 2011. PMID: 21651404


  10. Masharani UB, Maddux BA, Li X, Sakkas GK, Mulligan K, Schambelan M, Goldfine ID, Youngren JF. Insulin resistance in non-obese subjects is associated with activation of the JNK pathway and impaired insulin signaling in skeletal muscle. PloS one 2011. PMID: 21589939


  11. Weinberg ME, Roman MC, Jacob P, Wen M, Cheung P, Walker UA, Mulligan K, Schambelan M. Enhanced uridine bioavailability following administration of a triacetyluridine-rich nutritional supplement. PloS one 2011. PMID: 21379380


  12. Taylor SA, Lee GA, Pao VY, Anthonypillai J, Aweeka FT, Schwarz JM, Mulligan K, Schambelan M, Grunfeld C. Boosting dose ritonavir does not alter peripheral insulin sensitivity in healthy HIV-seronegative volunteers. Volume 55 of Issue 3. Journal of acquired immune deficiency syndromes (1999) 2010. PMID: 20595906


  13. Rao MN, Mulligan K, Tai V, Wen MJ, Dyachenko A, Weinberg M, Li X, Lang T, Grunfeld C, Schwarz JM, Schambelan M. Effects of insulin-like growth factor (IGF)-I/IGF-binding protein-3 treatment on glucose metabolism and fat distribution in human immunodeficiency virus-infected patients with abdominal obesity and insulin resistance. Volume 95 of Issue 9. 2010. PMID: 20610601


  14. Shrestha S, Irvin MR, Taylor KD, Wiener HW, Pajewski NM, Haritunians T, Delaney JA, Schambelan M, Polak JF, Arnett DK, Chen YD, Grunfeld C. A genome-wide association study of carotid atherosclerosis in HIV-infected men. Volume 24 of Issue 4. AIDS (London, England) 2010. PMID: 20009918


  15. Pao VY, Lee GA, Taylor S, Aweeka FT, Schwarz JM, Mulligan K, Schambelan M, Grunfeld C. The protease inhibitor combination lopinavir/ritonavir does not decrease insulin secretion in healthy, HIV-seronegative volunteers. Volume 24 of Issue 2. AIDS (London, England) 2010. PMID: 19890203


  16. Sakkas GK, Schambelan M, Mulligan K. Can the use of creatine supplementation attenuate muscle loss in cachexia and wasting? Current opinion in clinical nutrition and metabolic care 2009. PMID: 19741514


  17. Campos GM, Rabl C, Peeva S, Ciovica R, Rao M, Schwarz JM, Havel P, Schambelan M, Mulligan K. Improvement in peripheral glucose uptake after gastric bypass surgery is observed only after substantial weight loss has occurred and correlates with the magnitude of weight lost. Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract 2009. PMID: 19838759


  18. Lee GA, Schwarz JM, Patzek S, Kim S, Dyachenko A, Wen M, Mulligan K, Schambelan M, Grunfeld C. The acute effects of HIV protease inhibitors on insulin suppression of glucose production in healthy HIV-negative men. Volume 52 of Issue 2. Journal of acquired immune deficiency syndromes (1999) 2009. PMID: 19680131


  19. Sakkas GK, Mulligan K, Dasilva M, Doyle JW, Khatami H, Schleich T, Kent-Braun JA, Schambelan M. Creatine fails to augment the benefits from resistance training in patients with HIV infection: a randomized, double-blind, placebo-controlled study. PloS one 2009. PMID: 19242554


  20. Mulligan K, Khatami H, Schwarz JM, Sakkas GK, DePaoli AM, Tai VW, Wen MJ, Lee GA, Grunfeld C, Schambelan M. The effects of recombinant human leptin on visceral fat, dyslipidemia, and insulin resistance in patients with human immunodeficiency virus-associated lipoatrophy and hypoleptinemia. Volume 94 of Issue 4. 2009. PMID: 19174500


  21. Schambelan M, Wilson PW, Yarasheski KE, Cade WT, Dávila-Román VG, D'Agostino RB, Helmy TA, Law M, Mondy KE, Nachman S, Peterson LR, Worm SW. Development of appropriate coronary heart disease risk prediction models in HIV-infected patients. Circulation 2008. PMID: 18566316


  22. Grinspoon SK, Grunfeld C, Kotler DP, Currier JS, Lundgren JD, Dubé MP, Lipshultz SE, Hsue PY, Squires K, Schambelan M, Wilson PW, Yarasheski KE, Hadigan CM, Stein JH, Eckel RH. State of the science conference: Initiative to decrease cardiovascular risk and increase quality of care for patients living with HIV/AIDS: executive summary. Volume 118 of Issue 2. Circulation 2008. PMID: 18566320


  23. Lee GA, Rao M, Mulligan K, Lo JC, Aweeka F, Schwarz JM, Schambelan M, Grunfeld C. Effects of ritonavir and amprenavir on insulin sensitivity in healthy volunteers. Volume 21 of Issue 16. AIDS (London, England) 2007. PMID: 18090045


  24. Li X, Youngren JF, Hyun B, Sakkas GK, Mulligan K, Majumdar S, Masharani UB, Schambelan M, Goldfine ID. Technical evaluation of in vivo abdominal fat and IMCL quantification using MRI and MRSI at 3 T. Magnetic resonance imaging 2007. PMID: 17683890


  25. Mulligan K, Zackin R, Von Roenn JH, Chesney MA, Egorin MJ, Sattler FR, Benson CA, Liu T, Umbleja T, Shriver S, Auchus RJ, Schambelan M. Testosterone supplementation of megestrol therapy does not enhance lean tissue accrual in men with human immunodeficiency virus-associated weight loss: a randomized, double-blind, placebo-controlled, multicenter trial. The Journal of clinical endocrinology and metabolism 2006. PMID: 17090640


  26. Lee GA, Lo JC, Aweeka F, Schwarz JM, Mulligan K, Schambelan M, Grunfeld C. Single-dose lopinavir-ritonavir acutely inhibits insulin-mediated glucose disposal in healthy volunteers. Volume 43 of Issue 5. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2006. PMID: 16886163


  27. Lo JC, Kazemi MR, Hsue PY, Martin JN, Deeks SG, Schambelan M, Mulligan K. The relationship between nucleoside analogue treatment duration, insulin resistance, and fasting arterialized lactate level in patients with HIV infection. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2005. PMID: 16206112


  28. Schwarz JM, Lee GA, Park S, Noor MA, Lee J, Wen M, Lo JC, Mulligan K, Schambelan M, Grunfeld C. Indinavir increases glucose production in healthy HIV-negative men. Volume 18 of Issue 13. AIDS (London, England) 2004. PMID: 15316349


  29. Lo JC, Mulligan K, Noor MA, Lee GA, Schwarz JM, Grunfeld C, Schambelan M. The effects of low-dose growth hormone in HIV-infected men with fat accumulation: a pilot study. Volume 39 of Issue 5. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2004. PMID: 15356790


  30. Lee GA, Mafong DD, Noor MA, Lo JC, Mulligan K, Schwarz JM, Schambelan M, Grunfeld C. HIV protease inhibitors increase adiponectin levels in HIV-negative men. Volume 36 of Issue 1. Journal of acquired immune deficiency syndromes (1999) 2004. PMID: 15097312


  31. Lee GA, Seneviratne T, Noor MA, Lo JC, Schwarz JM, Aweeka FT, Mulligan K, Schambelan M, Grunfeld C. The metabolic effects of lopinavir/ritonavir in HIV-negative men. Volume 18 of Issue 4. AIDS (London, England) 2004. PMID: 15090769


  32. Zambon AC, McDearmon EL, Salomonis N, Vranizan KM, Johansen KL, Adey D, Takahashi JS, Schambelan M, Conklin BR. Time- and exercise-dependent gene regulation in human skeletal muscle. Genome biology 2003. PMID: 14519196


  33. Abrams DI, Hilton JF, Leiser RJ, Shade SB, Elbeik TA, Aweeka FT, Benowitz NL, Bredt BM, Kosel B, Aberg JA, Deeks SG, Mitchell TF, Mulligan K, Bacchetti P, McCune JM, Schambelan M. Short-term effects of cannabinoids in patients with HIV-1 infection: a randomized, placebo-controlled clinical trial. Annals of internal medicine 2003. PMID: 12965981


  34. Schambelan M, Benson CA, Carr A, Currier JS, Dubé MP, Gerber JG, Grinspoon SK, Grunfeld C, Kotler DP, Mulligan K, Powderly WG, Saag MS, International AIDS Society-USA. Management of metabolic complications associated with antiretroviral therapy for HIV-1 infection: recommendations of an International AIDS Society-USA panel. Journal of acquired immune deficiency syndromes (1999) 2002. PMID: 12439201


  35. Tai VW, Schambelan M, Algren H, Shayevich C, Mulligan K. Effects of recombinant human growth hormone on fat distribution in patients with human immunodeficiency virus-associated wasting. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2002. PMID: 12410487


  36. Mulligan K, Schambelan M. Anabolic treatment with GH, IGF-I, or anabolic steroids in patients with HIV-associated wasting. International journal of cardiology 2002. PMID: 12163220


  37. Napolitano LA, Lo JC, Gotway MB, Mulligan K, Barbour JD, Schmidt D, Grant RM, Halvorsen RA, Schambelan M, McCune JM. Increased thymic mass and circulating naive CD4 T cells in HIV-1-infected adults treated with growth hormone. AIDS (London, England) 2002. PMID: 12004268


  38. Noor MA, Seneviratne T, Aweeka FT, Lo JC, Schwarz JM, Mulligan K, Schambelan M, Grunfeld C. Indinavir acutely inhibits insulin-stimulated glucose disposal in humans: a randomized, placebo-controlled study. AIDS (London, England) 2002. PMID: 11964551


  39. Schwarz JM, Mulligan K, Lee J, Lo JC, Wen M, Noor MA, Grunfeld C, Schambelan M. Effects of recombinant human growth hormone on hepatic lipid and carbohydrate metabolism in HIV-infected patients with fat accumulation. The Journal of clinical endocrinology and metabolism 2002. PMID: 11836345


  40. Lo JC, Mulligan K, Noor MA, Schwarz JM, Halvorsen RA, Grunfeld C, Schambelan M. The effects of recombinant human growth hormone on body composition and glucose metabolism in HIV-infected patients with fat accumulation. The Journal of clinical endocrinology and metabolism 2001. PMID: 11502767


  41. Lo JC, Schambelan M. Reproductive function in human immunodeficiency virus infection. The Journal of clinical endocrinology and metabolism 2001. PMID: 11397819


  42. Noor MA, Lo JC, Mulligan K, Schwarz JM, Halvorsen RA, Schambelan M, Grunfeld C. Metabolic effects of indinavir in healthy HIV-seronegative men. AIDS (London, England) 2001. PMID: 11399973


  43. Mulligan K, Tai VW, Algren H, Abrams DI, Leiser RJ, Lo JC, Schambelan M. Altered fat distribution in HIV-positive men on nucleoside analog reverse transcriptase inhibitor therapy. Journal of acquired immune deficiency syndromes (1999) 2001. PMID: 11391163


  44. Kaplan G, Thomas S, Fierer DS, Mulligan K, Haslett PA, Fessel WJ, Smith LG, Kook KA, Stirling D, Schambelan M. Thalidomide for the treatment of AIDS-associated wasting. AIDS research and human retroviruses 2000. PMID: 11018854


  45. Giacchetti G, Sechi LA, Griffin CA, Don BR, Mantero F, Schambelan M. The tissue renin-angiotensin system in rats with fructose-induced hypertension: overexpression of type 1 angiotensin II receptor in adipose tissue. Journal of hypertension 2000. PMID: 10872553


  46. Mulligan K, Grunfeld C, Tai VW, Algren H, Pang M, Chernoff DN, Lo JC, Schambelan M. Hyperlipidemia and insulin resistance are induced by protease inhibitors independent of changes in body composition in patients with HIV infection. Journal of acquired immune deficiency syndromes (1999) 2000. PMID: 10708054


  47. Khovidhunkit W, Memon RA, Shigenaga JK, Pang M, Schambelan M, Mulligan K, Feingold KR, Grunfeld C. Plasma platelet-activating factor acetylhydrolase activity in human immunodeficiency virus infection and the acquired immunodeficiency syndrome. Metabolism: clinical and experimental 1999. PMID: 10599983


  48. Mulligan K, Tai VW, Schambelan M. Use of growth hormone and other anabolic agents in AIDS wasting. JPEN. Journal of parenteral and enteral nutrition 1999. PMID: 10571456


  50. Westphal CH, Muller L, Zhou A, Zhu X, Bonner-Weir S, Schambelan M, Steiner DF, Lindberg I, Leder P. The neuroendocrine protein 7B2 is required for peptide hormone processing in vivo and provides a novel mechanism for pituitary Cushing's disease. Cell 1999. PMID: 10089884


  51. Lo JC, Mulligan K, Tai VW, Algren H, Schambelan M. Body shape changes in HIV-infected patients. Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association 1998. PMID: 9803975


  52. Engler MM, Schambelan M, Engler MB, Ball DL, Goodfriend TL. Effects of dietary gamma-linolenic acid on blood pressure and adrenal angiotensin receptors in hypertensive rats. Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.) 1998. PMID: 9648942


  53. Johansen KL, Mulligan K, Tai V, Schambelan M. Leptin, body composition, and indices of malnutrition in patients on dialysis. Journal of the American Society of Nephrology : JASN 1998. PMID: 9621292


  55. Lo JC, Mulligan K, Tai VW, Algren H, Schambelan M. "Buffalo hump" in men with HIV-1 infection. Lancet (London, England) 1998. PMID: 9525364


  56. Sechi LA, Griffin CA, Zingaro L, Catena C, De Carli S, Schambelan M, Bartoli E. Glucose metabolism and insulin receptor binding and mRNA levels in tissues of Dahl hypertensive rats. American journal of hypertension 1997. PMID: 9397240


  57. Deeks SG, Coleman RL, White R, Pachl C, Schambelan M, Chernoff DN, Feinberg MB. Variance of plasma human immunodeficiency virus type 1 RNA levels measured by branched DNA within and between days. The Journal of infectious diseases 1997. PMID: 9237721


  58. Sechi LA, Griffin CA, Zingaro L, Valentin JP, Bartoli E, Schambelan M. Effects of angiotensin II on insulin receptor binding and mRNA levels in normal and diabetic rats. Diabetologia 1997. PMID: 9243097


  59. Mulligan K, Tai VW, Schambelan M. Cross-sectional and longitudinal evaluation of body composition in men with HIV infection. Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association 1997. PMID: 9215653


  60. Valentin JP, Sechi LA, Griffin CA, Humphreys MH, Schambelan M. The renin-angiotensin system and compensatory renal hypertrophy in the rat. American journal of hypertension 1997. PMID: 9128205


  61. Mulligan K, Tai VW, Schambelan M. Energy expenditure in human immunodeficiency virus infection. The New England journal of medicine 1997. PMID: 8984340


  62. Griffin CA, Giacchetti G, Schambelan M, Sechi LA. Ontogenic expression of renal and hepatic angiotensin II receptor genes in the rat. Nephron 1997. PMID: 9171308


  63. Sechi LA, Ceriello A, Griffin CA, Catena C, Amstad P, Schambelan M, Bartoli E. Renal antioxidant enzyme mRNA levels are increased in rats with experimental diabetes mellitus. Diabetologia 1997. PMID: 9028714


  64. Schambelan M, Mulligan K, Grunfeld C, Daar ES, LaMarca A, Kotler DP, Wang J, Bozzette SA, Breitmeyer JB. Recombinant human growth hormone in patients with HIV-associated wasting. A randomized, placebo-controlled trial. Serostim Study Group. Annals of internal medicine 1996. PMID: 8967667


  65. Meiner VL, Cases S, Myers HM, Sande ER, Bellosta S, Schambelan M, Pitas RE, McGuire J, Herz J, Farese RV. Disruption of the acyl-CoA:cholesterol acyltransferase gene in mice: evidence suggesting multiple cholesterol esterification enzymes in mammals. Proceedings of the National Academy of Sciences of the United States of America 1996. PMID: 8943057


  66. Sechi LA, Griffin CA, Giacchetti G, Valentin JP, Llorens-Cortes C, Corvol P, Schambelan M. Tissue-specific regulation of type 1 angiotensin II receptor mRNA levels in the rat. Hypertension (Dallas, Tex. : 1979) 1996. PMID: 8794824


  67. Benowitz NL, Zevin S, Carlsen S, Wright J, Schambelan M, Cheitlin M. Orthostatic hypertension due to vascular adrenergic hypersensitivity. Hypertension (Dallas, Tex. : 1979) 1996. PMID: 8675262


  68. Papadakis MA, Grady D, Black D, Tierney MJ, Gooding GA, Schambelan M, Grunfeld C. Growth hormone replacement in healthy older men improves body composition but not functional ability. Annals of internal medicine 1996. PMID: 8633830


  69. Sechi LA, Griffin CA, Giacchetti G, Zingaro L, Catena C, Bartoli E, Schambelan M. Abnormalities of insulin receptors in spontaneously hypertensive rats. Hypertension (Dallas, Tex. : 1979) 1996. PMID: 8613274


  70. Jeunemaitre X, Charru A, Pascoe L, Guyene TT, Aupetit-Faisant B, Shackleton CH, Schambelan M, Plouin PF, Corvol P. [Hyperaldosteronism sensitive to dexamethasone with adrenal adenoma. Clinical, biological and genetic study]. Presse medicale (Paris, France : 1983) 1995. PMID: 7501605


  71. Sechi LA, Valentin JP, Griffin CA, Lee E, Bartoli E, Humphreys MH, Schambelan M. Receptors for atrial natriuretic peptide are decreased in the kidney of rats with streptozotocin-induced diabetes mellitus. The Journal of clinical investigation 1995. PMID: 7769090


  72. Shimkets RA, Warnock DG, Bositis CM, Nelson-Williams C, Hansson JH, Schambelan M, Gill JR, Ulick S, Milora RV, Findling JW. Liddle's syndrome: heritable human hypertension caused by mutations in the beta subunit of the epithelial sodium channel. Cell 1994. PMID: 7954808


  73. Sechi LA, Griffin CA, Schambelan M. The cardiac renin-angiotensin system in STZ-induced diabetes. Diabetes 1994. PMID: 7926285


  74. Valentin JP, Sechi LA, Griffin CA, Humphreys MH, Schambelan M. [Gene expression of the renin-angiotensin system in compensatory renal hypertrophy secondary to contralateral nephrectomy]. Archives des maladies du coeur et des vaisseaux 1994. PMID: 7755471


  75. Schambelan M. Licorice ingestion and blood pressure regulating hormones. Steroids 1994. PMID: 8191541


  76. Sechi LA, Griffin CA, Schambelan M. Effect of dietary sodium chloride on insulin receptor number and mRNA levels in rat kidney. The American journal of physiology 1994. PMID: 8304482


  77. Valentin JP, Sechi LA, Griffin CA, Humphreys MH, Schambelan M. Renin-angiotensin system gene expression during compensatory renal hypertrophy in the rat. Journal of hypertension. Supplement : official journal of the International Society of Hypertension 1993. PMID: 8158362


  78. Kalinyak JE, Sechi LA, Griffin CA, Don BR, Tavangar K, Kraemer FB, Hoffman AR, Schambelan M. The renin-angiotensin system in streptozotocin-induced diabetes mellitus in the rat. Journal of the American Society of Nephrology : JASN 1993. PMID: 8130360


  79. Sechi LA, Griffin CA, De Carli S, Sechi G, Schambelan M, Bartoli E. [Angiotensin II receptors in the heart conduction tissue]. Minerva cardioangiologica 1993. PMID: 8127452


  80. Mulligan K, Grunfeld C, Hellerstein MK, Neese RA, Schambelan M. Anabolic effects of recombinant human growth hormone in patients with wasting associated with human immunodeficiency virus infection. The Journal of clinical endocrinology and metabolism 1993. PMID: 8408471


  81. Sechi LA, Sechi G, De Carli S, Griffin CA, Schambelan M, Bartoli E. [The role of G-regulatory proteins in the intracellular mechanism of cardiac angiotensin-II receptors]. Cardiologia (Rome, Italy) 1993. PMID: 8313407


  82. Sechi LA, Valentin JP, Griffin CA, Schambelan M. Autoradiographic characterization of angiotensin II receptor subtypes in rat intestine. The American journal of physiology 1993. PMID: 8338170


  83. Sechi LA, Sechi G, De Carli S, Griffin CA, Schambelan M, Bartoli E. [Angiotensin receptors in the rat myocardium during pre- and postnatal development]. Cardiologia (Rome, Italy) 1993. PMID: 8221742


  84. Valentin JP, Sechi LA, Qui C, Schambelan M, Humphreys MH. Urodilatin binds to and activates renal receptors for atrial natriuretic peptide. Hypertension (Dallas, Tex. : 1979) 1993. PMID: 8384600


  85. Masharani U, Schambelan M. The endocrine complications of acquired immunodeficiency syndrome. Advances in internal medicine 1993. PMID: 8438644


  86. Sechi LA, Griffin CA, Grady EF, Kalinyak JE, Schambelan M. Characterization of angiotensin II receptor subtypes in rat heart. Circulation research 1992. PMID: 1423940


  87. Ray PE, Schambelan M, Hintz R, Ruley EJ, Harrah J, Holliday MA. Plasma renin activity as a marker for growth failure due to sodium deficiency in young rats. Pediatric nephrology (Berlin, Germany) 1992. PMID: 1482638


  88. Sechi LA, Griffin CA, Grady EF, Grunfeld C, Kalinyak JE, Schambelan M. Tissue-specific regulation of insulin receptor mRNA levels in rats with STZ-induced diabetes mellitus. Diabetes 1992. PMID: 1386819


  89. al-Uzri A, Holliday MA, Gambertoglio JG, Schambelan M, Kogan BA, Don BR. An accurate practical method for estimating GFR in clinical studies using a constant subcutaneous infusion. Kidney international 1992. PMID: 1501425


  90. Sechi LA, Grady EF, Griffin CA, Kalinyak JE, Schambelan M. Distribution of angiotensin II receptor subtypes in rat and human kidney. The American journal of physiology 1992. PMID: 1539685


  91. Sechi LA, Grady EF, Griffin CA, Kalinyak JE, Schambelan M. Characterization of angiotensin II receptor subtypes in the rat kidney and heart using the non-peptide antagonists DuP 753 and PD 123 177. Journal of hypertension. Supplement : official journal of the International Society of Hypertension 1991. PMID: 1818953


  92. Sechi LA, Griffin CA, Grady EF, Kalinyak JE, Schambelan M. Insulin receptor concentration and gene expression are modulated by sodium intake in the rat kidney. Journal of hypertension. Supplement : official journal of the International Society of Hypertension 1991. PMID: 1818950


  93. Grady EF, Sechi LA, Griffin CA, Schambelan M, Kalinyak JE. Expression of AT2 receptors in the developing rat fetus. The Journal of clinical investigation 1991. PMID: 1885777


  94. Wada L, Don BR, Schambelan M. Hormonal mediators of amino acid-induced glomerular hyperfiltration in humans. The American journal of physiology 1991. PMID: 1647685


  95. Kaysen GA, Don B, Schambelan M. Proteinuria, albumin synthesis and hyperlipidaemia in the nephrotic syndrome. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 1991. PMID: 1857529


  96. Don BR, Kaysen GA, Hutchison FN, Schambelan M. The effect of angiotensin-converting enzyme inhibition and dietary protein restriction in the treatment of proteinuria. American journal of kidney diseases : the official journal of the National Kidney Foundation 1991. PMID: 1986564


  97. Anderson PW, Do YS, Schambelan M, Horton R, Boger RS, Luther RR, Hsueh WA. Effects of renin inhibition in systemic hypertension. The American journal of cardiology 1990. PMID: 2244565


  98. Don BR, Schambelan M. Hyperkalemia in acute glomerulonephritis due to transient hyporeninemic hypoaldosteronism. Kidney international 1990. PMID: 2074657


  99. Farese RV, Schambelan M, Hollander H, Stringari S, Jacobson MA. Nephrogenic diabetes insipidus associated with foscarnet treatment of cytomegalovirus retinitis. Annals of internal medicine 1990. PMID: 2160217


  100. Don BR, Sebastian A, Cheitlin M, Christiansen M, Schambelan M. Pseudohyperkalemia caused by fist clenching during phlebotomy. The New England journal of medicine 1990. PMID: 2325722


  101. Denolle T, Rohmer V, Saint-Adnré JP, Guyene TT, Galland F, Bigorgne JC, Schambelan M, Corvol P. Effect of the circulating renin-angiotensin system on prolactin release in humans. The Journal of clinical endocrinology and metabolism 1990. PMID: 2104627


  102. Don BR, Wada L, Kaysen GA, Schambelan M. Effect of dietary protein restriction and angiotensin converting enzyme inhibition on protein metabolism in the nephrotic syndrome. Kidney international. Supplement 1989. PMID: 2561515


  103. Noth RH, Krolewski AS, Kaysen GA, Meyer TW, Schambelan M. Diabetic nephropathy: hemodynamic basis and implications for disease management. Annals of internal medicine 1989. PMID: 2653154


  104. Don BR, Blake S, Hutchison FN, Kaysen GA, Schambelan M. Dietary protein intake modulates glomerular eicosanoid production in the rat. The American journal of physiology 1989. PMID: 2539749


  105. Toffelmire EB, Slater K, Corvol P, Menard J, Schambelan M. Response of plasma prorenin and active renin to chronic and acute alterations of renin secretion in normal humans. Studies using a direct immunoradiometric assay. The Journal of clinical investigation 1989. PMID: 2643635


  106. Schambelan M, Don BR, Kaysen GA, Blake S. Abnormalities of glomerular eicosanoid metabolism in states of glomerular hyperfiltration. Advances in experimental medicine and biology 1989. PMID: 2696356


  107. Don BR, Schambelan M. Diabetes, dietary protein and glomerular hyperfiltration. The Western journal of medicine 1987. PMID: 2891223


  108. Hutchinson FN, Schambelan M, Kaysen GA. Modulation of albuminuria by dietary protein and converting enzyme inhibition. The American journal of physiology 1987. PMID: 2821830


  109. Sebastian A, Schambelan M. Renal hyperkalemia. Seminars in nephrology 1987. PMID: 3317637


  110. Hernandez RE, Schambelan M, Cogan MG, Colman J, Morris RC, Sebastian A. Dietary NaCl determines severity of potassium depletion-induced metabolic alkalosis. Kidney international 1987. PMID: 3039234


  111. Schambelan M, Sebastian A, Katuna BA, Arteaga E. Adrenocortical hormone secretory response to chronic NH4Cl-induced metabolic acidosis. The American journal of physiology 1987. PMID: 3105328


  112. Hutchison FN, Don BR, Kaysen GA, Blake S, Schambelan M. Dietary protein intake modulates glomerular eicosanoid production in nephrotic rats. Advances in prostaglandin, thromboxane, and leukotriene research 1987. PMID: 2960179


  113. Lim RC, Nakayama DK, Biglieri EG, Schambelan M, Hunt TK. Primary aldosteronism: changing concepts in diagnosis and management. American journal of surgery 1986. PMID: 3728804


  114. Schambelan M, Blake S, Sraer J, Bens M, Nivez MP, Wahbe F. Increased prostaglandin production by glomeruli isolated from rats with streptozotocin-induced diabetes mellitus. The Journal of clinical investigation 1985. PMID: 3156147


  115. Kater CE, Biglieri EG, Rost CR, Schambelan M, Hirai J, Chang BC, Brust N. The constant plasma 18-hydroxycorticosterone to aldosterone ratio: an expression of the efficacy of corticosterone methyloxidase type II activity in disorders with variable aldosterone production. The Journal of clinical endocrinology and metabolism 1985. PMID: 2981240


  117. Arteaga E, Biglieri EG, Kater CE, Lopez JM, Schambelan M. Aldosterone-producing adrenocortical carcinoma. Preoperative recognition and course in three cases. Annals of internal medicine 1984. PMID: 6087704


  118. Maher T, Schambelan M, Kurtz I, Hulter HN, Jones JW, Sebastian A. Amelioration of metabolic acidosis by dietary potassium restriction in hyperkalemic patients with chronic renal insufficiency. The Journal of laboratory and clinical medicine 1984. PMID: 6366094


  120. Williams FA, Schambelan M, Biglieri EG, Carey RM. Acquired primary hypoaldosteronism due to an isolated zona glomerulosa defect. The New England journal of medicine 1983. PMID: 6316138


  121. Ardaillou N, Nivez MP, Schambelan M, Ardaillou R. Response of adenylate cyclase to parathyroid hormone and prostaglandins by human isolated glomeruli. The Journal of clinical endocrinology and metabolism 1983. PMID: 6355140


  122. Kurtz I, Maher T, Hulter HN, Schambelan M, Sebastian A. Effect of diet on plasma acid-base composition in normal humans. Kidney international 1983. PMID: 6663989


  123. Kater CE, Biglieri EG, Schambelan M, Arteaga E. Studies of impaired aldosterone response to spironolactone-induced renin and potassium elevations in adenomatous but not hyperplastic primary aldosteronism. Hypertension (Dallas, Tex. : 1979) 1983. PMID: 6360878


  124. Landefeld CS, Schambelan M, Kaplan SL, Embury SH. Clomiphene-responsive hypogonadism in sickle cell anemia. Annals of internal medicine 1983. PMID: 6414355


  125. Kirby BD, Ham J, Fairley HB, Benowitz N, Schambelan M. Normotensive pheochromocytoma. Pharmacologic, paraneoplastic and anesthetic considerations. The Western journal of medicine 1983. PMID: 6636736


  126. Sebastian A, Hulter HN, Kurtz I, Maher T, Schambelan M. Disorders of distal nephron function. The American journal of medicine 1982. PMID: 6277192


  127. Jones JW, Sebastian A, Hulter HN, Schambelan M, Sutton JM, Biglieri EG. Systemic and renal acid-base effects of chronic dietary potassium depletion in humans. Kidney international 1982. PMID: 7070001


  128. Biglieri EG, Schambelan M. Endocrine hypertension. Clinics in endocrinology and metabolism 1981. PMID: 7344806


  129. Perloff D, Schambelan M. Renovascular hypertension. Clinics in endocrinology and metabolism 1981. PMID: 7047020


  130. Humphreys MH, Al-Bander H, Eneas JF, Schambelan M. Factors determining electrolyte excretion and renin secretion after closure of an arteriovenous fistula in the dog. The Journal of laboratory and clinical medicine 1981. PMID: 7019367


  132. White RH, Schambelan M. Hypertension and angiographic findings in necrotizing vasculitis. Annals of internal medicine 1981. PMID: 7224395


  133. Rodriguez JA, Biglieri EG, Schambelan M. Pseudohyperaldosteronism with renal tubular resistance to mineralocorticoid hormones. Transactions of the Association of American Physicians 1981. PMID: 7046191


  134. White EA, Schambelan M, Rost CR, Biglieri EG, Moss AA, Korobkin M. Use of computed tomography in diagnosing the cause of primary aldosteronism. The New England journal of medicine 1980. PMID: 7432419


  135. Sebastian A, Sutton JM, Hulter HN, Schambelan M, Poler SM. Effect of mineralocorticoid replacement therapy on renal acid-base homeostasis in adrenalectomized patients. Kidney international 1980. PMID: 7206460


  136. Benowitz NL, Byrd R, Schambelan M, Rosenberg J, Roizen MF. Dihydroergotamine treatment for orthostatic hypotension from Vacor rodenticide. Annals of internal medicine 1980. PMID: 7356234


  137. White RH, Schambelan M. Hypertension, hyperreninemia, and secondary hyperaldosteronism in systemic necrotizing vasculitis. Annals of internal medicine 1980. PMID: 6101532


  138. Hulter HN, Sebastian A, Sigala JF, Licht JH, Glynn RD, Schambelan M, Biglieri EG. Pathogenesis of renal hyperchloremic acidosis resulting from dietary potassium restriction in the dog: role of aldosterone. The American journal of physiology 1980. PMID: 7361893


  139. Biglieri EG, Brust N, Chang B, Hirai J, Wajchenberg BL, Schambelan M. Clinical manifestation of adrenocorticotropin-determined plasma concentrations of mineralocorticoid hormones. Progress in biochemical pharmacology 1980. PMID: 6259660


  141. Biglieri EG, Chang B, Hirai J, Brust N, Rost CR, Schambelan M. Adrenocorticotropin inhibition of mineralocorticoid hormone production. Clinical science (London, England : 1979) 1979. PMID: 232023


  142. Biglieri EG, Schambelan M. The significance of elevated levels of plasma 18-hydroxycorticosterone in patients with primary aldosteronism. The Journal of clinical endocrinology and metabolism 1979. PMID: 447820


  143. Schambelan M, Sebastian A. Hyporeninemic hypoaldosteronism. Advances in internal medicine 1979. PMID: 34320


  144. Sebastian A, Schambelan M, Lindenfeld S, Morris RC. Amelioration of metabolic acidosis with fludrocortisone therapy in hyporeninemic hypoaldosteronism. The New England journal of medicine 1977. PMID: 18672


  145. Hogan MJ, Schambelan M, Biglieri EG. Concurrent hypercortisolism and hypermineralocorticoidism. The American journal of medicine 1977. PMID: 871129


  146. Potter DE, Schambelan M, Salvatierra O, Orloff S, Holliday MA. Treatment of high-renin hypertension with propranolol in children after renal transplantation. The Journal of pediatrics 1977. PMID: 318685


  147. Baxter JD, Schambelan M, Matulich DT, Spindler BJ, Bartter FC. Role of steroids in hypertension: evaluation of plasma mineralocorticoid activity with aldosterone receptors. Clinical science and molecular medicine. Supplement 1976. PMID: 1071637


  148. Matulich DT, Spindler BJ, Schambelan M, Baxter JD. Mineralocorticoid receptors in human kidney. The Journal of clinical endocrinology and metabolism 1976. PMID: 993320


  149. Baxter JD, Schambelan M, Matulich DT, Spindler BJ, Taylor AA, Bartter FC. Aldosterone receptors and the evaluation of plasma mineralocorticoid activity in normal and hypertensive states. The Journal of clinical investigation 1976. PMID: 182723


  150. Kershnar AK, Borut D, Kogut MD, Biglieri EG, Schambelan M. Studies in a phenotypic female with 17-alpha-hydroxylase deficiency. The Journal of pediatrics 1976. PMID: 182944


  151. Schambelan M, Brust NL, Chang BC, Slater KL, Biglieri EG. Circadian rhythm and effect of posture on plasma aldosterone concentration in primary aldosteronism. The Journal of clinical endocrinology and metabolism 1976. PMID: 947931


  152. Hogan MJ, McRae J, Schambelan M, Biglieri EG. Location of aldosterone-producing adenomas with 131I-19-iodocholesterol. The New England journal of medicine 1976. PMID: 1246308


  153. Korobkin M, Glickman MG, Schambelan M. Segmental renal vein sampling for renin. Radiology 1976. PMID: 1250963


  154. Hunt TK, Schambelan M, Biglieri EG. Selection of patients and operative approach in primary aldosteronism. Annals of surgery 1975. PMID: 1180575


  155. Schambelan M. Letter: Hyporeninemic hypoaldosteronism in chronic renal disease. Metabolism: clinical and experimental 1975. PMID: 1128240


  156. Clark OH, Hall AD, Schambelan M. Clinical manifestations of adrenal hemorrhage. American journal of surgery 1974. PMID: 4846502


  157. Schambelan M, Glickman M, Stockigt JR, Biglieri EG. Selective renal-vein renin sampling in hypertensive patients with segmental renal lesions. The New England journal of medicine 1974. PMID: 4824011


  158. Golde DW, Schambelan M, Weintraub BD, Rosen SW. Gonadotropin-secreting renal carcinoma. Cancer 1974. PMID: 4819211


  159. Eichner HL, Schambelan M, Biglieri EG. Systemic lupus erythematosus with adrenal insufficiency. The American journal of medicine 1973. PMID: 4356101


  160. Schambelan M, Howes EL, Noakes CA, Biglieri EG. Role of renin and aldosterone in hypertension due to a renin-secreting tumor. The American journal of medicine 1973. PMID: 4715934


  161. Stockigt JR, Hertz P, Schambelan M, Biglieri EG. Segmental renal-vein renin sampling for segmental renal infarction. Studies in a hypertensive patient. Annals of internal medicine 1973. PMID: 4352785


  162. Schambelan M, Stockigt JR, Biglieri EG. Isolated hypoaldosteronism in adults. A renin-deficiency syndrome. The New England journal of medicine 1972. PMID: 4341275


  163. Stockigt JR, Collins RD, Noakes CA, Schambelan M, Biglieri EG. Renal-vein renin in various forms of renal hypertension. Lancet (London, England) 1972. PMID: 4113187


  164. Biglieri EG, Stockigt JR, Schambelan M. Adrenal mineralocorticoids causing hypertension. The American journal of medicine 1972. PMID: 4556934


  165. Schambelan M, Biglieri EG. Deoxycorticosterone production and regulation in man. The Journal of clinical endocrinology and metabolism 1972. PMID: 4335105


  166. Schambelan M, Slaton PE, Biglieri EG. Mineralocorticoid production in hyperadrenocorticism. Role in pathogenesis of hypokalemic alkalosis. The American journal of medicine 1971. PMID: 4329978


  167. Biglieri EG, Stockigt JR, Schambelan M. A preliminary evaluation for primary aldosteronism. Archives of internal medicine 1970. PMID: 5483593


  168. Biglieri EG, Schambelan M, Slaton PE, Stockigt JR. The intercurrent hypertension of primary aldosteronism. Circulation research 1970. PMID: 5423298


  169. Schambelan M, Slaton PE, Murray JF, Biglieri EG. Adrenal insufficiency and inappropriate secretion of antidiuretic hormone. Occurrence in a patient with carcinoma of the lung. Archives of internal medicine 1969. PMID: 5797078


  170. Slaton PE, Schambelan M, Biglieri EG. Stimulation and suppression of aldosterone secretion in patients with an aldosterone-producing adenoma. The Journal of clinical endocrinology and metabolism 1969. PMID: 4303579


  171. Biglieri EG, Slaton PE, Schambelan M, Kronfield SJ. Hypermineralocorticoidism. The American journal of medicine 1968. PMID: 4299067


  172. Schambelan M, Sussman S. Encephalitis and purpura with influenza infection. A case report. American journal of diseases of children (1960) 1966. PMID: 5904471